Dr Gloria Gonzalez-Aseguinolaza, Chief Scientific Officer of Vivet Therapeutics Receives the Rosalind Franklin Society Special Award in Science
Recognition of her pioneering gene therapy research Coordinated the first ever gene therapy clinical trial utilizing AAVs as a vector for the treatment of an inherited liver metabolic disease for acute intermittent porphyria Her work on AAVs has been instrumental in creating Vivet’s research platform and advancing development of Vivet’s lead gene therapy for Wilson’s […]
